Global Cosmetics Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Published Date: 2021-03-20
- Report ID: 72163
- Pages: 134
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales.Prudent Markets published a report for global Cosmetics market in this environment.
In terms of revenue, this research report indicated that the global Cosmetics market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Cosmetics industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Allergan aims at producing XX K Units Cosmetics in 2020, with XX % production to take place in global market, Merz Aesthetics accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Cosmetics Market byPrudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Cosmetics Market
Allergan
Merz Aesthetics
Galderma
Valeant Pharmaceuticals
Mentor Worldwide
Anika Therapeutics
Adoderm
Teoxane
Laboratories Vivacy
Prollenium Medical
Speciality European Pharma
Laboratories Orgv
MD Skin Solutions
Laboratoires Filorga
Revitacare
Suneva Medical
SciVision Biotech
...
Major Type of Cosmetics Covered inPrudent Markets report:
Facial Surgical Procedures
Non-Surgical Procedures
Application Segments Covered inPrudent Markets Market
Beauty Salon
Hospital
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Cosmetics Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Facial Surgical Procedures -Product Introduction and Major Manufacturers
1.1.2 Non-Surgical Procedures -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Cosmetics Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Cosmetics Market
3.1.1 Top Companies leading Cosmetics Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Cosmetics Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Cosmetics Market
3.2.1 Top Companies leading Cosmetics Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Cosmetics Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Cosmetics Market
3.3.1 Top Companies leading Cosmetics Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Cosmetics Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Cosmetics Market
3.4.1 Top Companies leading Cosmetics Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Cosmetics Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Cosmetics Market
3.5.1 Top Companies leading Cosmetics Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Cosmetics Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Cosmetics Market
3.6.1 Top Companies leading Cosmetics Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Cosmetics Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Cosmetics Market
3.7.1 Top Companies leading Cosmetics Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Cosmetics Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Cosmetics Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Cosmetics Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Cosmetics Sales and Growth Rate (2021-2027)
5.2 Global Cosmetics Sales Value and Growth Rate (2021-2027)
6 Cosmetics Competitive Analysis
6.1 Allergan
6.1.1 Allergan Company Profiles
6.1.2 Allergan Product Introduction
6.1.3 Allergan Cosmetics Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Merz Aesthetics
6.2.1 Merz Aesthetics Company Profiles
6.2.2 Merz Aesthetics Product Introduction
6.2.3 Merz Aesthetics Cosmetics Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Galderma
6.3.1 Galderma Company Profiles
6.3.2 Galderma Product Introduction
6.3.3 Galderma Cosmetics Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Valeant Pharmaceuticals
6.4.1 Valeant Pharmaceuticals Company Profiles
6.4.2 Valeant Pharmaceuticals Product Introduction
6.4.3 Valeant Pharmaceuticals Cosmetics Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Mentor Worldwide
6.5.1 Mentor Worldwide Company Profiles
6.5.2 Mentor Worldwide Product Introduction
6.5.3 Mentor Worldwide Cosmetics Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Anika Therapeutics
6.6.1 Anika Therapeutics Company Profiles
6.6.2 Anika Therapeutics Product Introduction
6.6.3 Anika Therapeutics Cosmetics Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Adoderm
6.7.1 Adoderm Company Profiles
6.7.2 Adoderm Product Introduction
6.7.3 Adoderm Cosmetics Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Teoxane
6.8.1 Teoxane Company Profiles
6.8.2 Teoxane Product Introduction
6.8.3 Teoxane Cosmetics Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Laboratories Vivacy
6.9.1 Laboratories Vivacy Company Profiles
6.9.2 Laboratories Vivacy Product Introduction
6.9.3 Laboratories Vivacy Cosmetics Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Prollenium Medical
6.10.1 Prollenium Medical Company Profiles
6.10.2 Prollenium Medical Product Introduction
6.10.3 Prollenium Medical Cosmetics Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Speciality European Pharma
6.12 Laboratories Orgv
6.13 MD Skin Solutions
6.14 Laboratoires Filorga
6.15 Revitacare
6.16 Suneva Medical
6.17 SciVision Biotech
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
